Danilon Equidos Sachets 3g pk60

SKU
1003186

Danilon Equidos Sachets for the treatment of pain and inflammation associated with musculo-skeletal conditions in the horse eg osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation.

SPC_1916348.PDF (defra.gov.uk)

View more
In stock

Danilon Equidos Sachets for the treatment of pain and inflammation associated with musculo-skeletal conditions in the horse eg osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation

For oral administration.

When added to a portion of feed the product will be accepted by most horses.

The following should be used as a guide, according to individual response:

Horses: For a 480 kg bodyweight horse, the contents of 2 sachets should be administered twice daily (equivalent to 12.5 mg of suxibuzone/kg/day) for 2 days, followed by 1 sachet twice daily (6.25 mg of suxibuzone/kg/day) for 3 days.

Thereafter, 1 sachet daily (3.1 mg of suxibuzone/kg/day) or on alternate days, or the minimum dose frequency necessary for a satisfactory clinical response.

Ponies: Ponies should receive only half the dose rate recommended for horses.

For a 240 kg bodyweight pony, the contents of 1 sachet should be administered daily (equivalent to 6.25 mg of suxibuzone/kg/day) for 2 days, followed by 1 sachet on alternate days.

Thereafter, reduce to the minimum dose frequency necessary for a satisfactory clinical response. Hay, as part of the diet, may delay the absorption of suxibuzone and so the onset of clinical effect.

It is advisable not to feed hay immediately prior to, or with the veterinary medicinal product. See also 4.5. If no clinical response is evident after 4-5 days, discontinue treatment and reconsider the diagnosis.

Part sachets should not be used.

Do not administer together with other NSAIDs concurrently or within 24 hours of each other.

Not to be used in animals intended for human consumption

Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.

This veterinary medicinal product does not require any special storage conditions.

Each 3 g of Danilon Equidos sachet contains:

Active substance:

Suxibuzone (microencapsulated) 1.5 g

Excipient(s):

Tartrazine (E102) 0.37 mg

Tartrazine (E102)

Mannitol

Sucrose

Povidone K-30

Sodium saccharin

Ethyl Cellulose 20

Shelf life of the veterinary medicinal product as packaged for sale: 4 years

This veterinary medicinal product does not require any special storage conditions.

Do not administer together with other NSAIDs concurrently or within 24 hours of each other.

Not to be used in animals intended for human consumption

Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.

This veterinary medicinal product does not require any special storage conditions.